ITEM 8.01. OTHER EVENTS.

On May 14, 2020, Pulse Biosciences, Inc. (the "Company") issued a press release announcing the commencement of its previously-announced rights offering pursuant to a shelf registration statement filed on Form S-3 (File No. 333-237577), as amended, with the Securities and Exchange Commission, which was declared effective May 8, 2020.

A copy of the press release related to the matters set forth herein is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS



    (d)       Exhibits.

Exhibit No.   Description
   99.1       Press Release issued by Pulse Biosciences, Inc. dated May 14, 2020.


--------------------------------------------------------------------------------

© Edgar Online, source Glimpses